298) Implementation of the triage system, risk assessment scores, and telemedicine s |
299) o REVEAL-based and ESC/ERS criteria-based risk assessment strategies improved mortal |
300) rovide information on chemical hazard and risk assessment to avoid the use of intact |
301) ile conceptual developments in cumulative risk assessment to inform a more holistic |
302) evidence-based guidelines, point-of-care risk assessment tools, tailored education |
303) clinical/survey assessment, and suicidal risk assessment. |
304) urvival to age 85+ in the Atherosclerosis Risk in Communities study, and found signi |
305) tify and analyze published data on cancer risk in Cannabis users. |
306) es aimed at reducing diet-related disease risk in East Asian immigrant populations. |
307) ur results support organ-specific genetic risk in OS in a compelling candidate, MAGI |
308) oundation for understanding environmental risk in genetic studies of diverse populat |
309) nces, neurotoxicity, and increased cancer risk in humans. |
310) Key factors indicative of cardiovascular risk in isolated systolic hypertension wer |
311) assessing disease severity and mortality risk in pulmonary arterial hypertension (P |
312) sociation between Cannabis use and cancer risk in the United States. |
313) ur understanding of what elevates suicide risk in veterans with schizophrenia as a f |
314) e suggests that a large proportion of GDM risk in women may be preventable by lifest |
315) racteristics indicative of cardiovascular risk in young males (aged 18 to 30 years |
316) Risk perception varied geographically alon |
317) al, and social drivers of population heat risk perception and how they interact to i |
318) research demonstrates a link between heat risk perception and population response to |
319) lished up to March 2020 and investigating risk perception determinants for respirato |
320) A miscellaneous operationalization of risk perception emerged, including the lik |
321) Understanding the determinants of risk perception for COVID-19 might help to |
322) evidence on the possible determinants of risk perception for COVID-like diseases. |
323) Results revealed risk perception influences a person's expo |
324) mptoms, fatigue, daily activities, stroke risk factors, and cognitive exertion. |
325) ead to better health care outcomes, lower risk factors, and improved interventions r |
326) odemographic correlates, associations, or risk factors, and nine studies examined me |
327) Prognosis/ risk factors, epidemiology, and coagulatio |
328) Establishing risk factors, examining sex differences an |
329) e captured detailed data on demographics, risk factors, pre-COVID-19 Rockwood frailt |
330) addressed prevalence, severity, etiology, risk factors, preventive methods, screenin |
|